Sign up
Log in
12 Health Care Stocks Moving In Tuesday's After-Market Session
Share
Listen to the news

Gainers

  • Bio Green Med Solution (NASDAQ:BGMSP) stock moved upwards by 10.9% to $3.15 during Tuesday's after-market session.
  • bioAffinity Technologies (NASDAQ:BIAF) shares rose 10.58% to $3.03. The company's market cap stands at $8.5 million. The company's, Q4 earnings came out 2 days ago.
  • High Tide (NASDAQ:HITI) shares increased by 7.63% to $2.68. The market value of their outstanding shares is at $218.7 million. As per the press release, Q1 earnings came out today.
  • Apimeds Pharmaceuticals (AMEX:APUS) stock increased by 7.22% to $1.78. The company's market cap stands at $20.6 million.
  • GridAI Technologies (NASDAQ:GRDX) stock increased by 6.88% to $2.33. The company's market cap stands at $8.0 million.
  • Dare Bioscience (NASDAQ:DARE) shares rose 6.08% to $1.54. The market value of their outstanding shares is at $21.0 million.

Losers

  • Sharps Technology (NASDAQ:STSS) stock declined by 10.9% to $1.71 during Tuesday's after-market session. The market value of their outstanding shares is at $56.8 million.
  • Lunai Bioworks (NASDAQ:LNAI) shares decreased by 10.44% to $0.5. The market value of their outstanding shares is at $5.1 million.
  • Akari Therapeutics (NASDAQ:AKTX) stock fell 9.68% to $0.2. The market value of their outstanding shares is at $7.3 million.
  • Scienture Holdings (NASDAQ:SCNX) shares fell 8.7% to $0.44. The company's market cap stands at $18.4 million.
  • Longeveron (NASDAQ:LGVN) shares decreased by 7.32% to $0.89. The market value of their outstanding shares is at $18.9 million. As per the news, the Q4 earnings report came out today.
  • Kestra Medical Techs (NASDAQ:KMTS) stock fell 7.01% to $19.66. The market value of their outstanding shares is at $1.1 billion. The company's, Q3 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.